Shuting Sun

Shuting Sun

Dr. Shuting Sun is a medicinal chemist focusing on multifunctional phosphonate based drug actives and imaging probes. She received her PhD at the University of Southern California. Dr. Sun cofounded BioVinc in 2013 where she is Chief Scientist and COO. She also works as co-PI and co-investigator on several NIH grants, focusing on the development of bone-targeted therapeutics and diagnostics. Her work has led to critical research findings in the fields of bone metabolism, dental abnormalities and cochlear abnormalities, which is accelerating BioVinc to achieve its goal to develop innovative new diagnostic tools and therapeutic agents for bone-related diseases.

https://www.biovinc.com